⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for regorafenib 160mg or 120mg

Every month we try and update this database with for regorafenib 160mg or 120mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of RegorafenibNCT02800330
Colorectal Neop...
Gastrointestina...
Esomeprazole 40...
Esomeprazole 40...
Regorafenib 160...
18 Years - Erasmus Medical Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: